In this study, we analyzed expression levels of FBXO43 to infer promoter methylation levels in PBMCs among patients with HBV-associated HCC, chronic hepatitis B (CHB), and healthy controls (HCs), as well as the clinicopathological features. The gene discussed is FBXO43; the disease is hepatocellular carcinoma.